A LEADING CLINICAL-STAGE mRNA BIOTECH COMPANY
About Providence
Providence Therapeutics (PTx) is a Canadian RNA medicines company developing transformative vaccines for cancer treatment and protection from hard-to-treat infectious diseases.
With operations located in Calgary, Alberta and Toronto, Ontario, the Providence team offers a robust, clinically proven Ecosystem for the rapid development of mRNA-based therapeutics.
The Providence mRNA Ecosystem is a platform for Drug Developers
The Team
The Providence executive team is made up of dedicated experts who boast over 100 years of cumulative industry experience with extensive expertise in RNA therapeutics.
The Team
The Providence executive team is made up of dedicated experts who boast over 100 years of cumulative industry experience with extensive expertise in RNA therapeutics.
Technology
Our mRNA Ecosystem provides Providence Therapeutics with an agile, robust, clinically proven ecosystem for the rapid development of mRNA-based therapeutics, both internally and for partners/collaborators.
Providence Therapeutics' Made-in-Canada COVID-19 mRNA Vaccine
COVID-19 Vaccine Application
From its inception until the beginning of the COVID-19 pandemic in 2020, PTx was focused on developing personalized cancer vaccines for glioblastoma and ovarian cancer.
The Company was within months of launching its first phase 1 study in oncology when the pandemic hit.
Pipeline
Discover Providence's Cutting-Edge mRNA Pipeline in Infectious Diseases & Oncology
News & Media
Careers & Culture
Join Providence Therapeutics and embrace more than a career in biotech; immerse yourself in a lifestyle enriched by Calgary's dynamic blend of urban sophistication and natural beauty. Ranked high on the Economist Intelligence Unit's Livability Index, Calgary promises a fulfilling life with its safety, stability, education, healthcare, and vibrant culture.
Providence is thrilled to be certified as a Great Place to Work® in Canada for the second year!
Business Development
Providence not only aims to be part of the critical global mRNA COVID vaccine supply pool, but we also look to apply our mRNA platform technology towards various vaccine developments by establishing key collaborations with industry players in the various fields of cancers, therapies and infectious diseases.
Providence is looking for fit-for-purpose opportunities to work with therapeutics developers that may require using PTx’s lipids and LNP library towards various therapeutics and vaccine developments.
We extend our invitation to Biotech Industry players, the scientific community, and Academia that wish to discuss viable potential projects that our mRNA platform could play a vital role in.
Get In Touch
For Investor Relations, Business Development Opportunities, Media Relations, or General Inquiries, Contact Us.
